Cargando…
Expression analysis of novel biomarkers for breast cancer
Autores principales: | Laversin, SA, Miles, AK, Ball, GR, Gritzapis, AD, Perez, S, Baxevanis, C, Li, G, Rees, RC |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3300768/ http://dx.doi.org/10.1186/bcr1949 |
Ejemplares similares
-
Linking tumor with systemic environment in the search for novel biomarkers in breast cancer
por: Fortis, Sotirios P, et al.
Publicado: (2015) -
DRB1*11 allele expression and HER2 pre-existing immunity may predict benefit in breast cancer patients vaccinated with the HER2 modified AE37 peptide vaccine
por: Anastasopoulou, Eleftheria A, et al.
Publicado: (2015) -
Immune profiling of breast cancer patients: relationship between tumour antigen T cell responses with suppressor and effector leukocyte populations
por: Janssen, Nicole, et al.
Publicado: (2015) -
Fractal analysis: a new biomarker for determining clot characteristics in critically ill patients
por: Davies, GR, et al.
Publicado: (2012) -
Redirecting mouse T hybridoma against human breast and ovarian carcinomas: in vivo activity against HER-2/neu expressing cancer cells
por: Gritzapis, A D, et al.
Publicado: (2003)